In recent trading, shares of Ionis Pharmaceuticals Inc (Symbol: IONS) have crossed above the average analyst 12-month target price of $44.08, changing hands for $44.27/share. When a stock reaches the ...

Ionis Pharmaceuticals (IONS) has seen its stock climb nearly 11% over the past month, while shares are up 68% in the past 3 months. The company continues to attract attention as investors weigh its ...

Last month, a fire broke out at the EMR facility in South Camden, causing tremendous disruption, concern and anger throughout our city. I share these sentiments and believe that this incident affords ...

Ionis Pharmaceuticals' Q4 earnings beat expectations, but guidance for 2025 was slightly below consensus, leading to a HOLD rating pending further catalysts. TRYNGOLZA's approval for FCS is promising, ...

Ionis has faced a declining revenue trajectory over the medium term, with a 1.4% average annual drop over three years versus 5.3% growth for the S&P 500. The last twelve months reflect a steeper 7.6% ...

A move towards electric vehicles is essential to decarbonizing transport in line with the commitment to reduce and reverse climate change. The adoption of electrified transportation has increased in ...

The emission of carbon dioxide (CO₂) is one of the primary factors contributing to air pollution and climate change on Earth.